C2 C Wealth Management, LLC Bristol Myers Squibb CO Transaction History

C2 C Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $92,624 - $103,568	-1,600 Reduced 4.32%	35,477 $2.06 Million
Q2 2023 Jul 20, 2023	BUY	$63.71 - $70.74 $18,475 - $20,514	290 Added 0.79%	37,077 $2.37 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $742,785 - $842,487	11,304 Added 44.36%	36,787 $2.55 Million
Q4 2022 Feb 07, 2023	SELL	$68.48 - $81.09 $310,625 - $367,824	-4,536 Reduced 15.11%	25,483 $1.83 Million
Q3 2022 Oct 12, 2022	SELL	$0.13 - $76.84 $8 - $5,071	-66 Reduced 0.22%	30,019 $2.14 Million
Q1 2022 Apr 29, 2022	BUY	$61.48 - $73.72 $159,417 - $191,155	2,593 Added 9.43%	30,085 $2.31 Million
Q4 2021 Feb 23, 2022	BUY	$53.63 - $62.52 $1.47 Million - $1.72 Million	27,492 New	27,492 $1.71 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of C2 C Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on C2 C Wealth Management, LLC with notifications on news.